about
MPNs as Inflammatory Diseases: The Evidence, Consequences, and PerspectivesThe Role of Reactive Oxygen Species in Myelofibrosis and Related NeoplasmsInflammation as a Driver of Clonal Evolution in Myeloproliferative NeoplasmA 7-Gene Signature Depicts the Biochemical Profile of Early Prefibrotic MyelofibrosisRuxolitinib is manageable in patients with myelofibrosis and severe thrombocytopenia: a report on 12 Danish patients.The impact of ruxolitinib treatment on inflammation-mediated comorbidities in myelofibrosis and related neoplasmsChronic lymphocytic leukemia and myeloproliferative neoplasms concurrently diagnosed: clinical and biological characteristicsImmunological Consequences of JAK Inhibition: Friend or Foe?Interferon-alpha for the therapy of myeloproliferative neoplasms: targeting the malignant clone.Mathematical modelling as a proof of concept for MPNs as a human inflammation model for cancer developmentGATA1 insufficiencies in primary myelofibrosis and other hematopoietic disorders: consequences for therapy.Expression of CD markers in JAK2 positive myeloproliferative neoplasms: Prognostic significance
P2860
Q26775996-4EE5D24B-E5AF-493E-A969-C62443089243Q26779929-BA443B1E-AFF3-417B-A198-6A9F7C8B9346Q26779936-F3339BEF-4DF8-4139-BB76-2FE9B6D6CE83Q28553797-E8838C00-C365-4E5E-B172-8B2584C34BDDQ33422507-DFE35333-7DE1-4FC7-8B29-70287EC733E3Q35841839-DF8D160A-EE9D-40C1-9943-3C8073086F9FQ36814056-F5DDD13D-DC32-45F0-A1BE-C1179D6959E5Q38570383-159D44AC-ABB0-4E57-BDB3-262957B4243EQ38646051-92C5F33C-C06C-4D44-B991-2D70579B5429Q41576528-EDA3636E-399E-4F27-9AC2-DC98F61FBC8BQ50201003-6DEF0105-1069-47C2-A4CC-6446BC8445BAQ58587352-5C011BBF-8441-4610-91B4-DA1AEE2544FE
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
An immune dysregulation in MPN.
@en
type
label
An immune dysregulation in MPN.
@en
prefLabel
An immune dysregulation in MPN.
@en
P2860
P1476
An immune dysregulation in MPN.
@en
P2093
Giovanni Barosi
P2860
P2888
P304
P356
10.1007/S11899-014-0227-0
P577
2014-12-01T00:00:00Z
P6179
1044164317